Giulia C. Kennedy Ph.D.
Net Worth

Last updated:

What is Giulia C. Kennedy Ph.D. net worth?

The estimated net worth of Dr. Giulia C. Kennedy Ph.D. is at least $16,030,376 as of 6 Dec 2022. He owns shares worth $1,993,613 as insider, has earned $9,818,763 from insider trading and has received compensation worth at least $4,218,000 in Veracyte, Inc..

What is the salary of Giulia C. Kennedy Ph.D.?

Dr. Giulia C. Kennedy Ph.D. salary is $703,000 per year as Chief Scientific & Medical Officer in Veracyte, Inc..

How old is Giulia C. Kennedy Ph.D.?

Dr. Giulia C. Kennedy Ph.D. is 66 years old, born in 1959.

What stocks does Giulia C. Kennedy Ph.D. currently own?

As insider, Dr. Giulia C. Kennedy Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
Veracyte, Inc. (VCYT) Chief Scientific & Medical Officer 65,970 $30.22 $1,993,613

What does Veracyte, Inc. do?

Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; Percepta Genomic Sequencing Classifier and Percepta Nasal Swab Test for lung cancer diagnosis; Envisia Genomic Classifier for diagnosing interstitial lung disease, including idiopathic pulmonary fibrosis; and Immunoscore Colon Cancer test for colon cancer diagnosis. It is also developing Percepta Genomic Atlas to help inform lung cancer treatment decisions; Envisia Classifier, the nCounter analysis system; and LymphMark for lymphoma subtyping test. Veracyte, Inc. has technology licensing and collaboration arrangements with Johnson & Johnson; Acerta Pharma; and CareDx. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.

VCYT logo
VCYT
Veracyte, Inc.
$30.22

Giulia C. Kennedy Ph.D. insider trading

Veracyte, Inc.

Dr. Giulia C. Kennedy Ph.D. has made 39 insider trades between 2019-2022, according to the Form 4 filled with the SEC. Most recently he sold 1,023 units of VCYT stock worth $27,652 on 6 Dec 2022.

The largest trade he's ever made was exercising 52,015 units of VCYT stock on 4 Mar 2021. As of 6 Dec 2022 he still owns at least 65,970 units of VCYT stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 1,023 $27.03 $27,652
Sale
Common Stock 2 $29.34 $59
Option
Common Stock 2 $14.34 $29
Option
Stock Option (right to buy) 2 $14.34 $29
Sale
Common Stock 1,023 $25 $25,575
Option
Stock Option (right to buy) 1 $5.43 $5
Option
Common Stock 1 $5.43 $5
Sale
Common Stock 1,028 $26.54 $27,283
Option
Common Stock 2 $6.45 $13
Option
Common Stock 2 $10.45 $21
Sale
Common Stock 5,844 $25.7 $150,191
Option
Stock Option (right to buy) 4,407 $5.98 $26,354
Sale
Common Stock 100 $26.49 $2,649
Sale
Common Stock 100 $26.49 $2,649
Sale
Common Stock 17,089 $24.91 $425,704
Sale
Common Stock 17,059 $24.91 $424,940
Option
Common Stock 4,407 $5.98 $26,354
Sale
Common Stock 5,844 $25.7 $150,191
Option
Stock Option (right to buy) 14,281 $19.36 $276,452
Option
Common Stock 6,125 $25.62 $156,923
Sale
Common Stock 6,125 $40.62 $248,797
Sale
Common Stock 9,232 $36.25 $334,623
Option
Common Stock 8,156 $13.1 $106,803
Sale
Common Stock 926 $50.53 $46,791
Option
Common Stock 12,531 $16.96 $212,526
Option
Stock Option (right to buy) 12,531 $16.96 $212,526
Sale
Common Stock 12,531 $50.88 $637,527
Sale
Common Stock 4,375 $24.69 $108,019
Option
Stock Option (right to buy) 4,375 $24.69 $108,019
Option
Common Stock 4,375 $24.69 $108,019
Option
Stock Option (right to buy) 8,156 $13.1 $106,803
Sale
Common Stock 9,081 $34.28 $311,306
Option
Common Stock 8,156 $13.1 $106,803
Option
Common Stock 8,156 $13.1 $106,803
Sale
Common Stock 9,081 $34.28 $311,306
Option
Common Stock 30,970 $14.98 $464,024
Sale
Common Stock 52,015 $40.08 $2,084,709
Option
Stock Option (right to buy) 30,970 $8.44 $261,232
Sale
Common Stock 52,015 N/A N/A
Option
Stock Option (right to buy) 30,970 $14.98 $464,024
Option
Stock Option (right to buy) 30,970 N/A N/A
Sale
Common Stock 52,015 N/A N/A
Sale
Common Stock 52,015 $51.39 $2,672,895
Option
Common Stock 30,970 $6.17 $191,178
Option
Common Stock 13,468 $9.75 $131,353
Sale
Common Stock 14,015 $38.14 $534,476
Option
Stock Option (right to buy) 13,468 $5.01 $67,475
Option
Stock Option (right to buy) 13,468 $11.75 $158,209
Sale
Common Stock 14,015 $56.73 $795,057
Sale
Common Stock 2,500 N/A N/A
Option
Stock Option (right to buy) 2,500 N/A N/A
Option
Common Stock 2,500 N/A N/A
Option
Common Stock 6,479 N/A N/A
Option
Common Stock 6,479 $7.52 $48,690
Option
Stock Option (right to buy) 6,479 N/A N/A
Sale
Common Stock 7,027 N/A N/A
Sale
Common Stock 20,000 N/A N/A
Option
Common Stock 20,000 N/A N/A
Option
Stock Option (right to buy) 20,000 N/A N/A
Option
Common Stock 16,738 N/A N/A
Sale
Common Stock 16,738 $29.66 $496,365
Option
Stock Option (right to buy) 16,738 N/A N/A
Sale
Common Stock 16,738 N/A N/A
Option
Stock Option (right to buy) 10,239 N/A N/A
Option
Stock Option (right to buy) 10,239 $6.82 $69,830
Sale
Common Stock 10,786 N/A N/A
Option
Common Stock 10,239 N/A N/A
Option
Common Stock 15,033 N/A N/A
Sale
Common Stock 32,881 N/A N/A
Option
Stock Option (right to buy) 15,033 $6.73 $101,142
Option
Stock Option (right to buy) 15,033 N/A N/A
Option
Common Stock 15,033 $6.73 $101,142
Option
Common Stock 32,803 N/A N/A
Option
Stock Option (right to buy) 32,803 N/A N/A
Sale
Common Stock 32,803 N/A N/A
Sale
Common Stock 15,327 N/A N/A
Option
Stock Option (right to buy) 15,032 N/A N/A
Option
Common Stock 15,032 N/A N/A
Option
Stock Option (right to buy) 3,697 N/A N/A
Option
Common Stock 3,697 N/A N/A
Sale
Common Stock 3,697 N/A N/A
Sale
Common Stock 296 N/A N/A
Option
Stock Option (right to buy) 15,031 N/A N/A
Option
Common Stock 15,031 N/A N/A
Sale
Common Stock 15,031 N/A N/A
Option
Common Stock 4,640 N/A N/A
Option
Stock Option (right to buy) 4,640 N/A N/A
Sale
Common Stock 4,640 N/A N/A
Sale
Common Stock 28,257 N/A N/A
Option
Stock Option (right to buy) 27,962 N/A N/A
Option
Common Stock 27,962 N/A N/A
Option
Stock Option (right to buy) 17,625 N/A N/A
Sale
Common Stock 17,625 N/A N/A
Option
Common Stock 17,625 N/A N/A
Option
Stock Option (right to buy) 37,375 N/A N/A
Option
Common Stock 37,375 N/A N/A
Sale
Common Stock 37,375 N/A N/A

Veracyte key executives

Veracyte, Inc. executives and other stock owners filed with the SEC: